The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Helicobacter pylori treatment: antibiotics or probiotics
Open accessAbstract
Treatment of Helicobacter pylori infection is important for the management of gastrointestinal disorders such as peptic ulcer and gastric cancer. Due to the increase in the prevalence of H. pylori resistance to antibiotics, triple therapy with clarithromycin is no longer the best treatment for H. pylori, especially in some areas where the local resistance to this antibiotic is higher than 20%. Alternative treatments have been proposed for the eradication of H. pylori. Some of them including novel antibiotics or classical ones in different combinations; these treatments are being used in the regular clinical practice as novel and more effective treatments. Others therapies are using probiotics associated to antibiotics to treat this infection.The present article is a revision of H. pylori eradication treatment, focusing on emerging approaches to avoid the treatment failure, using new therapies with antimicrobials or with probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Guidelines for the evaluation of probiotics in food
Who, F. (2002) · Medical Entomology and Zoology · Cited by 1,843
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 853
Mack, D. R., Ahrne, S., Hyde, L., Wei, S., & Hollingsworth, M. A. (2003) · Gut · doi:10.1136/gut.52.6.827 · Cited by 666
Worldwide H. pylori antibiotic resistance: a systematic review.
Francesco, V. D., Giorgio, F., Hassan, C., et al. (2010) · PubMed · Cited by 480
A Report Card to Grade Helicobacter pylori Therapy
Graham, D. Y., Lu, H., & Yamaoka, Y. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00518.x · Cited by 393
In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain Shirota
Sgouras, D., Maragkoudakis, P., Petraki, K., Martinez-Gonzalez, B., Eriotou, E., Michopoulos, S., Kalantzopoulos, G., Tsakalidou, E., & Mentis, Α. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.1.518-526.2004 · Cited by 331
Helicobacter pylori and Probiotics1,
Lesbros-Pantoflickova, D., Corthèsy-Theulaz, I., & Blum, A. L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.812s · Cited by 262
TONG, J. L., RAN, Z. H., SHEN, J., ZHANG, C. X., & XIAO, S. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03179.x · Cited by 258
Cited by
Garcia-Castillo, V., Marcial, G., Albarracín, L., Tomokiyo, M., Clua, P., Takahashi, H., Kitazawa, H., Garcia-Cancino, A., & Villena, J. (2020) · Microorganisms · doi:10.3390/microorganisms8040479 · Cited by 34
Unveiling The Therapeutic Potential of Probiotics: A Review
Tukaram, K. S., Sopanrao, S. R., & Kacharu, L. O. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.09.011 · Cited by 19
Metadata
- Authors
- Goderska, K., Agudo Pena, S., & Alarcon, T.
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2017-10-26
- Volume
- 102
- Issue
- 1
- Pages
- 1-7
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- OpenAlex
- W2767202678
- Cited by
- 288
- References
- 46
- FWCI
- 28.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Helicobacter pylori treatment: antibiotics or probiotics. https://app.cochat.ai/papers/10.1007/s00253-017-8535-7
- The paper
- Goderska, K., Agudo Pena, S., & Alarcon, T. (2018). Helicobacter pylori treatment: antibiotics or probiotics. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-017-8535-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.